| Particulars |
| Company Name |
Concord Biotech Ltd |
Year End |
202603 |
| Full Year |
| Equity (Rs Cr.) |
20.92 |
B.V. Rs |
99.70 |
| Sales Rs Cr. |
1,055.07 |
NP Rs Cr. |
249.88 |
| NP Var% |
-30.00 |
Div% |
755.00 |
| CPS Rs |
15.50 |
EPS Rs |
11.90 |
| Traded Value(Rs Lakhs) |
186.62 |
52 Week High |
807.00 |
| 52 Week Low |
494.00 |
Price BSE |
598.00 |
| Price NSE |
597.00 |
Market Capital(Rs Cr.) |
12,504.77 |
| P/C Ratio |
38.60 |
P/E Ratio |
50.10 |
| Price Vs.BV |
6.00 |
|
| Latest Quarter |
| Year End |
202609 |
Sales Rs Cr. |
312.31 |
| NP Rs Cr. |
75.71 |
NP Var % |
20.00 |
| Trailing Twelve Months |
| Year End |
202609 |
Sales |
1,085.75 |
| OPM |
42.50 |
NP |
328.71 |
| NP Var% |
-7.56 |
EPS |
14.20 |
| PE |
42.09 |
|
|